Search - tctmd.com

Displaying 1 - 20 of 111

Sort: Relevancy | Date

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Conference News AHA 2016

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Michael O'Riordan

November 16, 2016

News Opinion Editor's Corner TCT 2016

我对 2016 年 TCT 的总结：惊喜、假设和赠品

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

News Opinion Editor's Corner TCT 2016

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Shelley Wood

November 07, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

Presentation TCT 2016

Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up

Presenter: Indulis Kumsars

November 01, 2016

Presentation TCT 2016

Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation

Presenter: Andreas Kristensen

November 01, 2016

Presentation TCT 2016

Back to BRS: Falcon, the Next Generation

Presenter: Ron Waksman, Robert-Jan van Geuns, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Presenter: Ron Waksman, Robert-Jan van Geuns, Olivier F. Bertrand

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Lifetech Iron-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Runlin Gao

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ArterioSorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

BRS Snapshots: The Biolute BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Dinesh Shah

October 31, 2016

Presentation TCT 2016

BRS Snapshots: XINSORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Lei Ge

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

Presenter: Ron Waksman, Robert-Jan van Geuns, Antoine Lafont

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Renuvia FAST

Presenter: Ron Waksman, Robert-Jan van Geuns, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

Presenter: Ron Waksman, Robert-Jan van Geuns, Guosheng Fu

October 31, 2016

Presentation TCT 2016

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Juan F. Granada

October 31, 2016

Presentation TCT 2016

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2016

Advertisement

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

我对 2016 年 TCT 的总结：惊喜、假设和赠品

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

Case #8: Absorb and Permanent DES in an LMCA Bifurcation With 3-year Follow-up

Case #7: All the Steps for This Absorb BRS Implanted in a Bifurcation

Back to BRS: Falcon, the Next Generation

BRS Snapshots: A Novel Biodegradable FE/316L Stent

BRS Snapshots: Lifetech Iron-Based BRS

BRS Snapshots: ArterioSorb

BRS Snapshots: The Biolute BRS

BRS Snapshots: XINSORB

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

BRS Snapshots: Renuvia FAST

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content